Trust Company of Vermont’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $405K | Buy |
4,247
+71
| +2% | +$6.96K | 0.02% | 277 |
|
|
2025
Q3 | $408K | Hold |
4,176
| – | – | 0.02% | 274 |
|
|
2025
Q2 | $449K | Sell |
4,176
-150
| -3% | -$15.2K | 0.02% | 263 |
|
|
2025
Q1 | $436K | Buy |
4,326
+50
| +1% | +$5.04K | 0.02% | 255 |
|
|
2024
Q4 | $382K | Hold |
4,276
| – | – | 0.02% | 282 |
|
|
2024
Q3 | $358K | Sell |
4,276
-495
| -10% | -$39K | 0.02% | 275 |
|
|
2024
Q2 | $367K | Sell |
4,771
-61
| -1% | -$4.46K | 0.02% | 253 |
|
|
2024
Q1 | $331K | Buy |
4,832
+430
| +10% | +$27.6K | 0.02% | 266 |
|
|
2023
Q4 | $254K | Sell |
4,402
-176
| -4% | -$9.39K | 0.02% | 261 |
|
|
2023
Q3 | $242K | Buy |
4,578
+1,388
| +44% | +$72.8K | 0.02% | 277 |
|
|
2023
Q2 | $173K | Buy |
3,190
+1,325
| +71% | +$69.2K | 0.01% | 320 |
|
|
2023
Q1 | $93.3K | Buy |
1,865
+75
| +4% | +$3.54K | 0.01% | 407 |
|
|
2022
Q4 | $82.8K | Hold |
1,790
| – | – | 0.01% | 411 |
|
|
2022
Q3 | $70K | Hold |
1,790
| – | – | 0.01% | 436 |
|
|
2022
Q2 | $67K | Buy |
+1,790
| New | +$72.9K | 0.01% | 441 |
|
|
2022
Q1 | – | Sell |
-1,678
| Closed | -$71K | – | 374 |
|
|
2021
Q4 | $71K | Buy |
+1,678
| New | +$70.5K | ﹤0.01% | 446 |
|
|
2021
Q3 | – | Sell |
-1,678
| Closed | -$72K | – | 366 |
|
|
2021
Q2 | $72K | Hold |
1,678
| – | – | 0.01% | 444 |
|
|
2021
Q1 | $65K | Hold |
1,678
| – | – | ﹤0.01% | 435 |
|
|
2020
Q4 | $60K | Sell |
1,678
-2,000
| -54% | -$72.1K | ﹤0.01% | 433 |
|
|
2020
Q3 | $141K | Buy |
3,678
+2,000
| +119% | +$77.1K | 0.01% | 316 |
|
|
2020
Q2 | $59K | Sell |
1,678
-4,191
| -71% | -$151K | 0.01% | 423 |
|
|
2020
Q1 | $192K | Buy |
5,869
+11
| +0.2% | +$430 | 0.02% | 280 |
|
|
2019
Q4 | $265K | Buy |
5,858
+32
| +0.5% | +$1.34K | 0.02% | 278 |
|
|
2019
Q3 | $237K | Hold |
5,826
| – | – | 0.02% | 292 |
|
|
2019
Q2 | $251K | Buy |
5,826
+800
| +16% | +$30.8K | 0.02% | 287 |
|
|
2019
Q1 | $193K | Sell |
5,026
-101
| -2% | -$3.86K | 0.02% | 311 |
|
|
2018
Q4 | $181K | Hold |
5,127
| – | – | 0.02% | 309 |
|
|
2018
Q3 | $198K | Hold |
5,127
| – | – | 0.02% | 323 |
|
|
2018
Q2 | $168K | Buy |
5,127
+906
| +21% | +$27.3K | 0.02% | 345 |
|
|
2018
Q1 | $116K | Hold |
4,221
| – | – | 0.01% | 379 |
|
|
2017
Q4 | $104K | Hold |
4,221
| – | – | 0.01% | 394 |
|
|
2017
Q3 | $123K | Hold |
4,221
| – | – | 0.01% | 380 |
|
|
2017
Q2 | $117K | Hold |
4,221
| – | – | 0.01% | 391 |
|
|
2017
Q1 | $105K | Sell |
4,221
-74
| -2% | -$1.8K | 0.01% | 391 |
|
|
2016
Q4 | $93K | Buy |
4,295
+74
| +2% | +$1.61K | 0.01% | 393 |
|
|
2016
Q3 | $100K | Buy |
4,221
+4,045
| +2,298% | +$96.5K | 0.01% | 347 |
|
|
2016
Q2 | $4K | Hold |
176
| – | – | ﹤0.01% | 739 |
|
|
2016
Q1 | $3K | Hold |
176
| – | – | ﹤0.01% | 688 |
|
|
2015
Q4 | $3K | Hold |
176
| – | – | ﹤0.01% | 715 |
|
|
2015
Q3 | $3K | Hold |
176
| – | – | ﹤0.01% | 731 |
|
|
2015
Q2 | $3K | Buy |
+176
| New | +$3.15K | ﹤0.01% | 759 |
|
Other funds holding BSX
Trust Company of Vermont's BSX Position: Q4 2025 in Review
Trust Company of Vermont increased its Boston Scientific (BSX) stake by 1.7% in Q4 2025, buying an estimated $6.96K and bringing the position to 4,247 shares worth $405K. The position accounts for 0.02% of the portfolio, ranked #277.
Trust Company of Vermont first reported a position in BSX in Q2 2015 and has held it in 41 quarters since. The position peaked at $449K in Q2 2025. 1,784 funds tracked by Wall St. Rank hold BSX as of Q4 2025.
- Trust Company of Vermont held 4,247 shares of Boston Scientific worth $405K as of Q4 2025.
- Trust Company of Vermont bought 71 Boston Scientific shares in Q4 2025, an estimated $6.96K.
- Boston Scientific made up 0.02% of Trust Company of Vermont's portfolio in Q4 2025, its #277 holding.
- Trust Company of Vermont first reported a position in Boston Scientific in Q2 2015 and has held it in 41 quarters since.
- Trust Company of Vermont's Boston Scientific position peaked at $449K in Q2 2025.
- 1,784 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.
Based on Trust Company of Vermont's 13F filing for Q4 2025, filed 16 Jan 2026.